Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia

Chandra Edwin; Roberto Lanes; Claude J. Migeon; Peter Lee; Leslie P. Plotnick; A. Avinoam Kowarski

doi:10.1016/S0022-3476(79)80757-X

Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia

Chandra Edwin, Roberto Lanes, Claude J. Migeon, Peter Lee, Leslie P. Plotnick, A. Avinoam Kowarski

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

The 24-hour integrated concentration of aldosterone, plasma renin activity, and 17-hydroxprogesteronewas measured simultaneously in 12 patients with congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency. Eight were salt-losers and four nonsalt-lowers. Seven normal children served as control subjects. All patients were receiving glucocorticoid replacement therapy (32 mg/m²/day). All but one of the SL-CVAH patients were also being treated with 9α-fluorocortisol. The mean (±SD) IC-PRA of the control subjects was 1.6±0.7 ng/ml/hour and in the NSL-CVAH patients was similar (1.6±0.7 and 2.2±1.0 ng/ml/hour). The IC-PRA of the SL-CVAH patients (21.1±28.8 ng/ml/hour) was significantly (P<0.001) higher than that of the normal subjects. The IC-ALDO/IC-PRA ratio of the control subjects and NSL-CVAH patients were 12.4±5.1 and 8.8±4.8, respectively. The ratio in SL-CVAH patients was significantly lower (2.0±1.4) than that of the control subjects (P<0.001). The lowered IC-AL DO/IC-PRA ratio in the SL-CVAH patients demonstrates the persistence of the 21-hydroxylase deficiency.

Original language	English (US)
Pages (from-to)	534-537
Number of pages	4
Journal	The Journal of Pediatrics
Volume	95
Issue number	4
DOIs	https://doi.org/10.1016/S0022-3476(79)80757-X
State	Published - Oct 1979

All Science Journal Classification (ASJC) codes

Pediatrics, Perinatology, and Child Health

Access to Document

10.1016/S0022-3476(79)80757-X

Fingerprint Dive into the research topics of 'Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia'. Together they form a unique fingerprint.

Cite this

@article{ff622794c89847c9a7bc06407b1b66e3,

title = "Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia",

abstract = "The 24-hour integrated concentration of aldosterone, plasma renin activity, and 17-hydroxprogesteronewas measured simultaneously in 12 patients with congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency. Eight were salt-losers and four nonsalt-lowers. Seven normal children served as control subjects. All patients were receiving glucocorticoid replacement therapy (32 mg/m2/day). All but one of the SL-CVAH patients were also being treated with 9α-fluorocortisol. The mean (±SD) IC-PRA of the control subjects was 1.6±0.7 ng/ml/hour and in the NSL-CVAH patients was similar (1.6±0.7 and 2.2±1.0 ng/ml/hour). The IC-PRA of the SL-CVAH patients (21.1±28.8 ng/ml/hour) was significantly (P<0.001) higher than that of the normal subjects. The IC-ALDO/IC-PRA ratio of the control subjects and NSL-CVAH patients were 12.4±5.1 and 8.8±4.8, respectively. The ratio in SL-CVAH patients was significantly lower (2.0±1.4) than that of the control subjects (P<0.001). The lowered IC-AL DO/IC-PRA ratio in the SL-CVAH patients demonstrates the persistence of the 21-hydroxylase deficiency.",

author = "Chandra Edwin and Roberto Lanes and Migeon, {Claude J.} and Peter Lee and Plotnick, {Leslie P.} and Kowarski, {A. Avinoam}",

year = "1979",

month = oct,

doi = "10.1016/S0022-3476(79)80757-X",

language = "English (US)",

volume = "95",

pages = "534--537",

journal = "Journal of Pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "4",

}

TY - JOUR

T1 - Persistence of the enzymatic block in adolescent patients with salt-losing congenital adrenal hyperplasia

AU - Edwin, Chandra

AU - Lanes, Roberto

AU - Migeon, Claude J.

AU - Lee, Peter

AU - Plotnick, Leslie P.

AU - Kowarski, A. Avinoam

PY - 1979/10

Y1 - 1979/10

N2 - The 24-hour integrated concentration of aldosterone, plasma renin activity, and 17-hydroxprogesteronewas measured simultaneously in 12 patients with congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency. Eight were salt-losers and four nonsalt-lowers. Seven normal children served as control subjects. All patients were receiving glucocorticoid replacement therapy (32 mg/m2/day). All but one of the SL-CVAH patients were also being treated with 9α-fluorocortisol. The mean (±SD) IC-PRA of the control subjects was 1.6±0.7 ng/ml/hour and in the NSL-CVAH patients was similar (1.6±0.7 and 2.2±1.0 ng/ml/hour). The IC-PRA of the SL-CVAH patients (21.1±28.8 ng/ml/hour) was significantly (P<0.001) higher than that of the normal subjects. The IC-ALDO/IC-PRA ratio of the control subjects and NSL-CVAH patients were 12.4±5.1 and 8.8±4.8, respectively. The ratio in SL-CVAH patients was significantly lower (2.0±1.4) than that of the control subjects (P<0.001). The lowered IC-AL DO/IC-PRA ratio in the SL-CVAH patients demonstrates the persistence of the 21-hydroxylase deficiency.

AB - The 24-hour integrated concentration of aldosterone, plasma renin activity, and 17-hydroxprogesteronewas measured simultaneously in 12 patients with congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency. Eight were salt-losers and four nonsalt-lowers. Seven normal children served as control subjects. All patients were receiving glucocorticoid replacement therapy (32 mg/m2/day). All but one of the SL-CVAH patients were also being treated with 9α-fluorocortisol. The mean (±SD) IC-PRA of the control subjects was 1.6±0.7 ng/ml/hour and in the NSL-CVAH patients was similar (1.6±0.7 and 2.2±1.0 ng/ml/hour). The IC-PRA of the SL-CVAH patients (21.1±28.8 ng/ml/hour) was significantly (P<0.001) higher than that of the normal subjects. The IC-ALDO/IC-PRA ratio of the control subjects and NSL-CVAH patients were 12.4±5.1 and 8.8±4.8, respectively. The ratio in SL-CVAH patients was significantly lower (2.0±1.4) than that of the control subjects (P<0.001). The lowered IC-AL DO/IC-PRA ratio in the SL-CVAH patients demonstrates the persistence of the 21-hydroxylase deficiency.

UR - http://www.scopus.com/inward/record.url?scp=0018292673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018292673&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(79)80757-X

DO - 10.1016/S0022-3476(79)80757-X

M3 - Article

C2 - 314501

AN - SCOPUS:0018292673

VL - 95

SP - 534

EP - 537

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 4

ER -